A novel eyedrop formulation of dexamethasone was found to reduce swelling and improve vision in a Phase II trial of patients with diabetic macular oedema (DME)
A model based on simple birth characteristics may provide a new, more efficient method for predicting the need for retinopathy of prematurity treatment in infants, according to researchers.
